The Albert B. Sabin Vaccine Institute, Inc.
Improving lives through immunization
Programs and results
What we aim to solve
Vaccines are one of the most successful health innovations in recent history, but the world is failing to reap the full benefits of immunization.
Childhood vaccination saves up to 3 million lives every year, but 1.5 million people still die each year from diseases that could have been prevented by vaccines.
Immunization is a best buy in global health, with a return of $16 for every $1 spent on immunization for the world's poorest children. When we account for broader economic and social benefits, the return on investment is much greater — up to 44 times the cost of vaccination.
Despite the enormous health and economic potential of vaccines, the world is failing to ensure everyone benefits from the promise of vaccines. One in seven children are missing out on basic vaccines. Now is the time to support countries to establish sustainable immunization programs to reach every child.
Successful immunization programs are the foundation of health care in every country in the world.
Our programs
What are the organization's current programs, how do they measure success, and who do the programs serve?
Global Immunization
Through our role at the intersection of immunization programs, policy and research, Sabin strives to empower immunization professionals, foster innovative thinking to advance next-generation vaccines, build public trust and ensure that vaccines reach every person that needs them.
Research & Development
Sabin is working to advance the development of vaccine candidates targeting diseases that impact the world's most vulnerable populations and is committed to ensuring equitable access to vaccines resulting from its R&D work.
Where we work
External reviews
Our results
How does this organization measure their results? It's a hard question but an important one.
Total number of organization members
This metric is no longer tracked.Totals By Year
Type of Metric
Output - describing our activities and reach
Direction of Success
Increasing
Context Notes
Boost is the only global network for immunization professionals and currently includes nearly 1000 active members from over 115 countries. Tailored to immunization professionals, Boost provides intera
Goals & Strategy
Learn about the organization's key goals, strategies, capabilities, and progress.
Charting impact
Four powerful questions that require reflection about what really matters - results.
What is the organization aiming to accomplish?
Lasting solutions cannot be imposed; they must be built. That is why we are dedicated to the development of country-driven, evidence-based responses to the world's leading health problems.
At Sabin, we believe in the power of vaccines to change the world. We seek a future free from vaccine-preventable diseases. We deliver sustainable, evidence-based solutions that extend the benefits of immunization to everyone, everywhere.
We carry on the legacy of Dr. Albert B. Sabin, best known for his creation of the oral polio vaccine in the 1950s, which was used in the global effort to eradicate polio. His vaccine saved countless millions around the world from death and disability, thanks to Dr. Sabin's tireless commitment to ensure that every child was protected from preventable disease. This dedication to reach every child with life-saving vaccines continues to inspire our work today.
What are the organization's key strategies for making this happen?
Global Immunization
Through our role at the intersection of immunization programs, policy and research, Sabin strives to empower immunization professionals, foster innovative thinking to advance next-generation vaccines, build public trust and ensure that vaccines reach every person that needs them.
Vaccine Research & Development
Sabin is working to advance the development of vaccine candidates targeting diseases that impact the world's most vulnerable populations and is committed to ensuring equitable access to vaccines resulting from its R&D work.
What are the organization's capabilities for doing this?
The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation.
Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases.
As a non-profit with more than two decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of immunization to all people, regardless of who they are or where they live.
What have they accomplished so far and what's next?
Typhoid
A new typhoid conjugate vaccine protecting children as young as 6 months of age offers the prospect of reducing the impact of this frequently overlooked disease — causing an estimated 128,000 deaths annually. Sabin’s landmark study to establish the burden of enteric fever on Southeast Asian communities and health care systems is providing key evidence to support introduction of this new vaccine into routine immunization schedules.
Ebola Sudan and Marburg
The Sudan strain of Ebola, along with the closely-related Marburg virus, are among the world’s deadliest diseases, causing hemorrhagic fever and death in an average of 50 percent of cases. With $20 million in initial funding from the U.S. Department of Health and Human Services, Sabin plans to advance an investigational vaccine through Phase 2 clinical trials.
Vaccine Acceptance
Delay or refusal of vaccination is one of the 10 greatest threats to our health, according to the World Health Organization. Through a series of grant-making programs, social and behavioral research, media education initiatives and
public advocacy campaigns, Sabin is a catalyst for informed decision making that boosts vaccine access and confidence.
Influenza
The next influenza pandemic could take an unprecedented toll: an estimated 33 million deaths within six months and a $6 trillion cost to the global economy. A universal influenza vaccine is key to preventing such devastation, but it remains an enormous challenge. By bringing together problem solvers from the worlds of science, technology and business, Sabin is creating a movement to address obstacles to vaccine development and make influenza history.
How we listen
Seeking feedback from people served makes programs more responsive and effective. Here’s how this organization is listening.
-
How is your organization using feedback from the people you serve?
To identify and remedy poor client service experiences, To identify bright spots and enhance positive service experiences, To make fundamental changes to our programs and/or operations, To inform the development of new programs/projects, To identify where we are less inclusive or equitable across demographic groups, To strengthen relationships with the people we serve
-
Which of the following feedback practices does your organization routinely carry out?
-
What challenges does the organization face when collecting feedback?
Financials
Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.
- Analyze a variety of pre-calculated financial metrics
- Access beautifully interactive analysis and comparison tools
- Compare nonprofit financials to similar organizations
Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more
about GuideStar Pro.
Operations
The people, governance practices, and partners that make the organization tick.
Connect with nonprofit leaders
SubscribeBuild relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.
- Analyze a variety of pre-calculated financial metrics
- Access beautifully interactive analysis and comparison tools
- Compare nonprofit financials to similar organizations
Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.
Connect with nonprofit leaders
SubscribeBuild relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.
- Analyze a variety of pre-calculated financial metrics
- Access beautifully interactive analysis and comparison tools
- Compare nonprofit financials to similar organizations
Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.
The Albert B. Sabin Vaccine Institute, Inc.
Board of directorsas of 11/02/2020
Dr. Axel Hoos
GlaxoSmithKline
Axel Hoos
Glaxo Smith Kline Pharmaceuticals
Philip Russell
Medical Researcher, Educator
Peter L. Thoren
Access Industries
Regina Rabinovich
Harvard University
Wendy Commins Holman
Ridgeback Biotherapeutics
Filip Dubovsky
Sabin Vaccine Institute
Elizabeth Fox
Pan American Development Foundation
Jeffrey P Libson
Cooley LLP
Saad Omer
Yale Institute of Global Health
David Salisbury
Global Health Security at Chatham House
Jacqueline Shea
Inovio Pharmaceuticals, Inc
Board leadership practices
GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.
-
Board orientation and education
Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? Yes -
CEO oversight
Has the board conducted a formal, written assessment of the chief executive within the past year ? Yes -
Ethics and transparency
Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes -
Board composition
Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes -
Board performance
Has the board conducted a formal, written self-assessment of its performance within the past three years? Yes